Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHC”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01200420
What this trial is testing

Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects

Who this might be right for
Hepatitis C
Santaris Pharma A/S 38
Not applicableUnknownNCT05081440
What this trial is testing

A Multi-center, Prospective, Observational Study to Describe the siTuation of Blood Lipid mAnagement Among the Population With hypeRtension and/or Type 2 diabeTes in Community Health Center

Who this might be right for
Lipoprotein Disorder
Huashan Hospital 5,000
Not applicableStudy completedNCT02508090
What this trial is testing

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 10
Large-scale testing (Phase 3)Study completedNCT00100659
What this trial is testing

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 114
Post-approval studies (Phase 4)Study completedNCT00087594
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 48
Post-approval studies (Phase 4)Study completedNCT02641379
What this trial is testing

Peginterferon Alfa-2a (Pegasys) When Administered in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 737
Testing effectiveness (Phase 2)Study completedNCT01899092
What this trial is testing

Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tacere Therapeutics, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT01726946
What this trial is testing

Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 10
Very early researchStudy completedNCT03188276
What this trial is testing

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 52
Testing effectiveness (Phase 2)Study completedNCT03020095
What this trial is testing

Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT02583685
What this trial is testing

Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 138
Not applicableStudy completedNCT02850289
What this trial is testing

APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 385
Not applicableStudy completedNCT03181074
What this trial is testing

Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 10
Post-approval studies (Phase 4)Study completedNCT00087568
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 57
Post-approval studies (Phase 4)Study completedNCT00686777
What this trial is testing

Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 75
Not applicableStudy completedNCT01850745
What this trial is testing

Multidisciplinary Support Program in Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Parc de Salut Mar 447
Not applicableUnknownNCT03887637
What this trial is testing

Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 180
Not applicableStudy completedNCT05310773
What this trial is testing

Couples Health CoOp Plus

Who this might be right for
HIVSubstance UseStigma, Social
RTI International 962
Early research (Phase 1)Study completedNCT02652377
What this trial is testing

EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients

Who this might be right for
Hepatitis C
Enanta Pharmaceuticals, Inc 100
Not applicableStudy completedNCT04214028
What this trial is testing

The Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation